CNS pipeline · person
Derek Small, B.S.
Co-founder and CEO of Syndeio Biosciences (formerly Gate Neurosciences). Founding Managing Director of Luson Bioventures; founding CEO of Naurex (acquired by Allergan in 2015) and Assembly Biosciences (Nasdaq: ASMB). Has overseen development of more than 10 novel CNS drug candidates and raised over $1 billion from life science investors.
- 1 company
Courtesy Syndeio Biosciences
Current roles
- Syndeio Biosciences, Inc.Co-founder and Chief Executive Officer · Founder
- Syndeio Biosciences, Inc.Chief Executive Officer · Executive
Appears with
People sharing a company with Derek.
- Anantha Shekhar · Syndeio Biosciences, Inc.
- Jacob Vogelstein · Syndeio Biosciences, Inc.
- John Donello · Syndeio Biosciences, Inc.
- Joseph R. Moskal · Syndeio Biosciences, Inc.
- Mark DiPaolo · Syndeio Biosciences, Inc.
- Michael G. McCully · Syndeio Biosciences, Inc.
- Pavel Raifeld · Syndeio Biosciences, Inc.
- Robert Berman · Syndeio Biosciences, Inc.
- Steve Brannan · Syndeio Biosciences, Inc.
- Thomas C. Sudhof · Syndeio Biosciences, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.